US defense firm Anduril raises $5 billion, doubling its valuation to $61 billion

Anduril raised $5 billion, doubling its valuation to $61 billion from $30.5 billion in a June 2025 round. The company said revenue more than doubled to $2.2 billion in 2025 and its workforce nearly doubled, underscoring rapid growth in defense tech amid the U.S.-Iran war. The round, led by Thrive Capital and Andreessen Horowitz, highlights strong investor appetite for private defense and autonomy platforms.

Analysis

The signal here is less about one private company and more about a new funding regime for defense technology: venture capital is now acting like quasi-permanent balance-sheet capacity for companies that would previously have needed public markets or prime contractors. That should keep compressing the window between product validation and scale, which is bullish for autonomous systems, battlefield software, and sensor fusion vendors with software-like gross margins and defense-like contract duration.

Second-order winners are likely to be the industrial enablers behind these platforms: C4ISR software, edge compute, secure semiconductors, RF components, and specialized manufacturing capacity. The real loser is the legacy procurement stack, because abundant private capital lets new entrants iterate faster, bid more aggressively, and tolerate longer contract cycles without dilutive pain. Expect incumbents to respond with accelerated M&A and pricing concessions, especially where autonomy can replace expensive manned or labor-intensive systems.

The market is probably underestimating how much private capital can distort valuation discipline across the broader defense-tech ecosystem. A $61B mark on a still-private platform raises the implied bar for every adjacent category, and that can pull forward financing for peers even if unit economics are not yet mature. The risk is that the current war-driven enthusiasm creates a financing bubble that outpaces actual program-of-record conversion; if geopolitical escalation cools or procurement rules slow, the multiple expansion could reverse faster than revenue growth, especially for names reliant on one or two headline customers.

For portfolio construction, the trade is not simply 'long defense' but long the picks-and-shovels plus selective short exposure to legacy contractors most exposed to autonomous displacement. The best risk/reward likely sits in public infrastructure and defense names with recurring software revenue or exposure to drone/sensor supply chains, while avoiding pure narrative beneficiaries that still need several years to prove margin durability. In a 6-12 month window, the catalyst path is continued conflict, additional mega-rounds, and follow-on contract wins; over 12-24 months, the key reversal risk is procurement friction and margin compression as competition intensifies.

Key Decisions for Investors

• Long AVAV vs short RTX as a pair trade over 6-12 months: favor the higher-beta autonomous system beneficiary over the incumbent with greater exposure to legacy procurement inertia and slower re-rating.
• Initiate a basket long in KLIC, ON, and NVDA on any 3-5% pullback over the next 1-4 weeks as 'defense autonomy enablers' — best risk/reward is through suppliers with secular demand but less valuation froth than the pure defense software names.
• Buy 6-12 month call spreads on PLTR or similar defense-software proxies only on weakness, not strength; the upside is continued multiple expansion if capital formation stays hot, but risk is valuation compression if the narrative outruns booked revenue.
• Short a basket of slow-moving legacy defense primes on strength, especially those with limited autonomous-drone exposure, as a hedge against procurement share loss; stop out if federal budgets shift decisively toward manned platform replenishment.
• If private-market defense rounds continue at this pace, consider a venture secondaries approach rather than primary exposure: buy exposure to late-stage defense-tech names at a discount through structured/private vehicles, targeting 2-3 year hold periods with lower entry valuation risk.